pepsico doesn't 'see any impact' from weight loss drugs: cfo
Published 9 months ago • 973 plays • Length 8:12Download video MP4
Download video MP3
Similar videos
-
3:58
pepsi and coke investors concerned about weight loss drugs' impact
-
3:11
analyst talks pepsico stock earnings, stock outlook, pricing, impact of weight loss drugs on sales
-
33:26
pepsico ceo on tackling inflation, weight-loss drugs and more | wsj
-
5:21
pepsi sees no hit from weight loss drugs
-
0:57
pepsico cfo on inflation: people are still buying doritos
-
7:30
pepsico cfo: the company will do well ‘regardless of the economic environment’
-
6:57
pepsico cfo on inflation: ‘we have no intention of cutting prices’
-
0:40
pepsico cfo on inflation: ‘we have no intention of cutting prices’
-
4:14
pepsico cfo on what the company has learned by navigating the pandemic
-
5:53
pepsico not seeing impact of ozempic on sales
-
3:56
pepsico ceo: brands that position themselves as sustainable are growing faster
-
2:10
jpmorgan downgrades pepsico stock to 'neutral'
-
8:59
pepsico q1 earnings: ‘the demand for our products continues to be quite high,’ cfo says
-
7:21
why eli lilly is a top pick to capitalize on glp-1 drug craze
-
0:31
diet pepsi without aspartame hits shelves
-
3:55
invest in pepsi: is weight loss drug fear overblown? #pep
-
0:53
what’s going on with pepsico shares?
-
0:27
pepsico hikes prices by double digits for the 7th consecutive quarter and profits jump 14%